DK1227323T4 - Ikke-A, ikke-B hepatitisvirusantigen, diagnostiske fremgangsmåder og vacciner - Google Patents

Ikke-A, ikke-B hepatitisvirusantigen, diagnostiske fremgangsmåder og vacciner

Info

Publication number
DK1227323T4
DK1227323T4 DK02006640.3T DK02006640T DK1227323T4 DK 1227323 T4 DK1227323 T4 DK 1227323T4 DK 02006640 T DK02006640 T DK 02006640T DK 1227323 T4 DK1227323 T4 DK 1227323T4
Authority
DK
Denmark
Prior art keywords
sequence
vaccines
nanbv
hutch
hcv
Prior art date
Application number
DK02006640.3T
Other languages
English (en)
Other versions
DK1227323T3 (da
Inventor
Genevieve Inchauspe
Alfred M Prince
Suzanne Zebedee
Marc S Nasoff
Original Assignee
Bioprocess Pty Ltd
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27416160&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1227323(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprocess Pty Ltd, Hoffmann La Roche filed Critical Bioprocess Pty Ltd
Application granted granted Critical
Publication of DK1227323T3 publication Critical patent/DK1227323T3/da
Publication of DK1227323T4 publication Critical patent/DK1227323T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK02006640.3T 1990-08-25 1991-08-23 Ikke-A, ikke-B hepatitisvirusantigen, diagnostiske fremgangsmåder og vacciner DK1227323T4 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57364390A 1990-08-25 1990-08-25
US61636990A 1990-11-21 1990-11-21
US74856491A 1991-08-21 1991-08-21
US2009010603 1991-08-23

Publications (2)

Publication Number Publication Date
DK1227323T3 DK1227323T3 (da) 2007-03-26
DK1227323T4 true DK1227323T4 (da) 2011-04-26

Family

ID=27416160

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02006640.3T DK1227323T4 (da) 1990-08-25 1991-08-23 Ikke-A, ikke-B hepatitisvirusantigen, diagnostiske fremgangsmåder og vacciner

Country Status (9)

Country Link
EP (2) EP0544838A4 (da)
KR (1) KR930702365A (da)
AT (1) ATE346302T1 (da)
AU (1) AU673135B2 (da)
CA (1) CA2090335A1 (da)
DE (1) DE69133552C5 (da)
DK (1) DK1227323T4 (da)
ES (1) ES2273934T5 (da)
WO (1) WO1992003458A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138784T3 (es) * 1990-12-14 2000-01-16 Innogenetics Nv Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
TW360711B (en) * 1991-06-10 1999-06-11 Lucky Ltd CDNAs of Korean hepatitis C virus and polypeptides encoded thereby
HU227547B1 (en) 1991-06-24 2011-08-29 Novartis Vaccines & Diagnostic Hepatitis c virus (hcv) polypeptides
ES2198514T3 (es) * 1991-08-27 2004-02-01 F. Hoffmann-La Roche Ag Cebadores y sondas para la deteccion de la hepatitis c.
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
US6153378A (en) * 1992-10-16 2000-11-28 Bionova Corporation Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
AU6415394A (en) * 1993-03-25 1994-10-11 Envirocon International Incorporated Test kits and methods for rapidly testing for contamination by microorganisms
GB9507232D0 (en) * 1995-04-07 1995-05-31 Gatsby Charitable Foundation Plant pathogen resistance genes and uses thereof
CN1061991C (zh) * 1994-06-08 2001-02-14 北京医科大学 新型血吸虫疫苗肽(三)
CN1068334C (zh) * 1994-06-08 2001-07-11 北京医科大学 新型血吸虫疫苗肽(二)
CN1061990C (zh) * 1994-06-08 2001-02-14 北京医科大学 新型血吸虫疫苗肽(一)
JP2005533855A (ja) 2002-07-24 2005-11-10 インターツェル・アクチェンゲゼルシャフト 病原性ウイルスからの別のリーディングフレームによりコードされる抗原
US7378234B2 (en) 2002-09-13 2008-05-27 Intercell Ag Method for isolating hepatitis C virus peptides
DE602004029657D1 (de) 2003-03-24 2010-12-02 Intercell Ag Verbesserte impfstoffe
CA2530062A1 (en) 2003-07-11 2005-01-20 Intercell Ag Hcv vaccines

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744242A1 (de) * 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
IE62868B1 (en) * 1987-11-18 1995-03-08 Chiron Corp Hepatitis C virus
AU624105B2 (en) * 1987-11-18 1992-06-04 Novartis Vaccines And Diagnostics, Inc. Nanbv diagnostics and vaccines
JPH04501203A (ja) * 1988-07-06 1992-03-05 ジェネラブズ　インコーポレイティド 後―輸血性，非―ａ，非―ｂ型肝炎ウィルス及び抗原
IL91371A0 (en) * 1988-08-24 1990-04-29 Us Commerce Clones or vectors bearing dna sequences of non-a and non-b hepatitis and a method for detecting these materials in blood
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
JPH02167081A (ja) * 1988-12-21 1990-06-27 Tetsuo Nakamura 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
UA50829C2 (uk) * 1989-03-17 2002-11-15 Чірон Корпорейшн Очищений поліпептид, що містить антиген вірусу гепатиту с, полінуклеотид, вектор, клітини, система експресії, моноклональне антитіло, препарат поліклональних антитіл, нуклеотидна проба, аналітичні набори, спосіб виявлення нуклеїнових кислот, способи імуноаналізу, вакцина, спосіб одержання антитіл

Also Published As

Publication number Publication date
ES2273934T5 (es) 2011-05-17
EP0544838A4 (en) 1997-09-10
ES2273934T3 (es) 2007-05-16
EP1227323B1 (en) 2006-11-22
EP1227323A1 (en) 2002-07-31
ATE346302T1 (de) 2006-12-15
DK1227323T3 (da) 2007-03-26
DE69133552D1 (de) 2007-01-04
EP1227323B2 (en) 2011-01-19
CA2090335A1 (en) 1992-02-26
EP0544838A1 (en) 1993-06-09
AU673135B2 (en) 1996-10-31
WO1992003458A1 (en) 1992-03-05
KR930702365A (ko) 1993-09-08
DE69133552C5 (de) 2008-01-10
DE69133552T2 (de) 2007-08-23
AU8904191A (en) 1992-03-17

Similar Documents

Publication Publication Date Title
DK1227323T3 (da) Ikke-A, ikke-B hepatitisvirusantigen, diagnostiske fremgangsmåder og vacciner
EP0992581B1 (en) Immunodominant human T-cell epitopes of hepatitis C virus
Nishizawa et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology
Battegay et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2. 1 molecules
ATE195953T1 (de) Peptide zur induktion von immunantwort durch zytotoxischen t lymphocyten gegen das virus von hepatitis c
MY110260A (en) Nanbv diagnostics and vaccines.
Kurokohchi et al. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region
CA2389206A1 (en) Activation of hcv-specific t cells
Matsuura et al. The molecular biology of hepatitis C virus
CA2505942A1 (en) West nile virus vaccine
EP0644894A1 (en) PEPTID FOR THE STIMULATION OF CYTOTOIC T LYMPHOCYTES SPECIFIC FOR HEPATITIS C VIRUS.
Höhne et al. Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak
WO2001021807A1 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
JP2005510244A5 (da)
WO1995032290A3 (en) Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
Honda et al. Sequence comparisons for a hepatitis C virus genome RNA isolated from a patient with liver cirrhosis
ATE115964T1 (de) Non-a non-b sequenzen.
RU2004104357A (ru) Вакцинный состав, потенцированный комбинацией днк и антигена
KR950000880A (ko) 한국형 씨(c)형 간염 바이러스의 일종인 케이에이치씨브이-엘2(khcv-l2)의 전체 뉴클레오티드서열 및 이로부터 유추된 아미노산 서열
MY105097A (en) Nanbv diagnostics and vaccines
KR950000881A (ko) 새로운 한국형 씨(C)형 간염 바이러스 씨디엔에이(cDNA) 절편의 뉴클레오티드 서열 및 이로부터 유추된 아미노산 서열
NO950527L (no) Analogifremgangsmåte ved fremstilling av non-A, non-B hepatittvirus-antigenpeptid